MUST Beg to Differ

Thomas Albini, Natalia F. Callaway, Glenn J. Jaffe, William Feuer, Janet Davis, Debra Goldstein, Careen Lowder, Phoebe Lin, Quan Nguyen, Sunil Srivastava, David Callanan, Anat Galor, Raquel Goldhardt, Harry Flynn

Research output: Contribution to journalEditorial


The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].

Original languageEnglish (US)
Pages (from-to)266-268
Number of pages3
JournalOphthalmic surgery, lasers & imaging retina
Issue number5
StatePublished - May 1 2019


ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this

Albini, T., Callaway, N. F., Jaffe, G. J., Feuer, W., Davis, J., Goldstein, D., Lowder, C., Lin, P., Nguyen, Q., Srivastava, S., Callanan, D., Galor, A., Goldhardt, R., & Flynn, H. (2019). MUST Beg to Differ. Ophthalmic surgery, lasers & imaging retina, 50(5), 266-268.